Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Medicine, Gynecology, Oncology +16

Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results

M. Piccart · JNCI Journal of the National Cancer Institute · 2000 · 1K citations · Full text

Medicine, Gynecology, Oncology +17

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Maurie Markman, Robert Rothman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 854 citations

Medicine, Gynecology, Oncology +13

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Dorina Belotti, Veronica Vergani, Teresa Drudis et al. · PubMed · 1996 · 646 citations

Medicine, Oncology, Pharmacology +13

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

Marjorie C. Green, Aman U. Buzdar, Terry Smith et al. · Journal of Clinical Oncology · 2005 · 421 citations

Medicine, Oncology, Pharmacology +15